SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51453Yet it seems to have worked for Singapore. Reduced viable longevity of smaller A.J. Mullen-6/19/2020
51452Seems obvious that when the probable vector shifted from droplet to aerosolized IRWIN JAMES FRANKEL26/19/2020
51451A Science paper is skeptical of the 6 ft distances recommended by CDC and othersA.J. Mullen36/18/2020
51450‘I can’t imagine going back’: Medicare leader calls for expanded telehealth acceA.J. Mullen-6/10/2020
51449There is also news that FGEN enrolled its first patient in pamrevlumab trial forArt Bechhoefer-6/8/2020
51448FGEN is flattish today because the success of the DOLOMITES study was already baDewDiligence_on_SI16/8/2020
51447FGEN down on press release? Would someone please explain? Thank you Roxadustatwalterenergy-6/8/2020
51446Some good news during the week was puzzling. Remdesivir seems to work when takeA.J. Mullen-6/7/2020
51445I didn't hear any reference to the numbers enrolled in the p3 trial for pamrArt Bechhoefer-6/5/2020
51444Has the company talked about how many patients have been enrolled in panrev P3 tsemi_infinite -6/5/2020
51443REGN appears to be investigating a monoclonal antibody that binds to GREM-1 to pArt Bechhoefer-6/5/2020
51442<Do you know what indications REGN is going after with their grem1 program?&gMiljenko Zuanic-6/5/2020
51441Do you know what indications REGN is going after with their grem1 program? ajp.semi_infinite -6/5/2020
51440Art, <I look for quality of management before considering anything else. So fMiljenko Zuanic-6/4/2020
51439The published test results for pamrevlumab so far look pretty good. There may bArt Bechhoefer-6/4/2020
51438RE: FGEN Pamr MoA and target (fibrosis) may not be bad idea, but compound itselfMiljenko Zuanic-6/4/2020
51437 <If you believe that if FGEN is bought by another company implies "non-Miljenko Zuanic16/4/2020
51436If you believe that if FGEN is bought by another company implies "non-existArt Bechhoefer-6/4/2020
51435Why is *FUTURE* of the FGEN acquisition? That is clear sign of NON EXISTING PRODMiljenko Zuanic-6/4/2020
51434Re: Hypothetical AZN-FGEN buyout For the kind of deal size we’re talking abouDewDiligence_on_SI16/3/2020
51433DewD -- There are several factors at play in an acquisition, not just cash or Art Bechhoefer-6/3/2020
51432Dew that makes sense because it's not possible in a big merger/acquisition olinhtu-6/2/2020
51431Big Pharma such as AZN almost never make an acquisition using stock unless the tDewDiligence_on_SI-6/2/2020
51430FGEN I would disappointed w such a deal. I'm looking for 100$ or more even ilinhtu-6/2/2020
51429FibroGen could be acquired by a company such as AstraZeneca. Consider the folloArt Bechhoefer-6/2/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News